Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer-Reference-Cited by-同舟云学术

Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer

Published:2022-06 Issue: Volume:346 Page:43-70
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Sharma Madhu,Bakshi Avijit Kumar,Mittapelly Naresh,Gautam Shalini,Marwaha Disha,Rai Nikhil,Singh Neha,Tiwari Pratiksha,Agarwal Neha,Kumar Ankit,Mishra Prabhat Ranjan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference287 articles.

1. The different mechanisms of cancer drug resistance: a brief review;Mansoori;Adv. Pharmaceut. Bull.,2017

2. Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence;Fleury;Nat. Commun.,2019

3. Drug-induced cell cycle modulation leading to cell-cycle arrest, nuclear mis-segregation, or endoreplication;Sakaue-Sawano;BMC Cell Biol.,2011

4. Antibiotics and bacterial resistance in the 21st century;Fair;Perspect. Med. Chem.,2014

5. A brief history of the antibiotic era: Lessons learned and challenges for the future;Aminov;Front. Microbiol.,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A carrier-free nanovaccine combined with cancer immunotherapy overcomes gemcitabine resistance;Biomaterials;2025-02

2. Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy;Heliyon;2024-09

3. Aptamer-modified GSH-sensitive honokiol polyprodrug nanoparticles for ovarian cancer-specific targeting therapy;2024-08-27

4. Alendronate-functionalized porous nano-crystalsomes mitigate osteolysis and consequent inhibition of tumor growth in a tibia-induced metastasis model;Journal of Controlled Release;2024-08

5. Ultrasound-assisted encapsulating folic acid-based carbon quantum dots within breast cancer cell-derived exosomes as a co-receptors-mediated anticancer nanocarrier for enhanced breast cancer therapy;Scientific Reports;2024-07-23